{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T05:15:07Z","timestamp":1771046107657,"version":"3.50.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2001,8,1]],"date-time":"2001-08-01T00:00:00Z","timestamp":996624000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2001,8]]},"DOI":"10.1054\/mehy.2001.1307","type":"journal-article","created":{"date-parts":[[2002,9,19]],"date-time":"2002-09-19T14:55:42Z","timestamp":1032447342000},"page":"151-155","source":"Crossref","is-referenced-by-count":70,"title":["The possible role of vitamin K deficiency in the pathogenesis of Alzheimer\u2019s disease and in augmenting brain damage associated with cardiovascular disease"],"prefix":"10.1054","volume":"57","author":[{"given":"A.C.","family":"Allison","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1054\/mehy.2001.1307_RF1","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2307\/3350099","article-title":"Estimated prevalence of Alzheimer\u2019s disease in the United States","volume":"68","author":"Evans","year":"1990","journal-title":"The Milbank Qtrly"},{"key":"10.1054\/mehy.2001.1307_RF2","doi-asserted-by":"crossref","unstructured":"Consensus report of the working group on: \u201cMolecular and biochemical markers of Alzheimer\u2019s disease\u201d. Neurobiology of Aging, 1998, 19, 109, 116.","DOI":"10.1016\/S0197-4580(98)00022-0"},{"key":"10.1054\/mehy.2001.1307_RF3","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1056\/NEJM199802193380804","article-title":"Utility of the apolipoprotein-E genotype in the diagnosis of Alzheimer\u2019s disease","volume":"338","author":"Mayeux","year":"1998","journal-title":"New Engl J Med"},{"key":"10.1054\/mehy.2001.1307_RF4","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1345\/aph.16378","article-title":"Pharmacologic management of Alzheimer\u2019s disease","volume":"33","author":"Flynn","year":"1999","journal-title":"Ann Pharmacother"},{"key":"10.1054\/mehy.2001.1307_RF5","doi-asserted-by":"crossref","unstructured":"Knopman, D. S. Advances in methodology and current prospects for primary drug therapies for Alzheimer\u2019s disease. Hooper, N.E. Methods in Molecular Medicine, Vol. 32. Alzheimer\u2019s disease: methods and protocols, Totowa NJ, Humana Press, 2000: 45\u201360.","DOI":"10.1385\/1-59259-195-7:45"},{"key":"10.1054\/mehy.2001.1307_RF6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.nu.15.070195.000245","article-title":"Role of vitamin K in metabolic bone disease","volume":"15","author":"Vermeer","year":"1995","journal-title":"Annu Rev Nutrition"},{"key":"10.1054\/mehy.2001.1307_RF7","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0026-0495(98)90220-7","article-title":"Decreased circulating levels of vitamin K and 25-hydroxyvitamin D in osteopenic elderly men","volume":"47","author":"Tamatani","year":"1998","journal-title":"Metabolism"},{"key":"10.1054\/mehy.2001.1307_RF8","doi-asserted-by":"crossref","first-page":"1192S","DOI":"10.1093\/jn\/126.suppl_4.1192S","article-title":"Transport of vitamin K to bones in humans","volume":"126","author":"Kohlmeier","year":"1996","journal-title":"J Nutr"},{"key":"10.1054\/mehy.2001.1307_RF9","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1093\/ajcn\/58.2.204","article-title":"Phylloquinone transport and its influence on \u03b3-carboxyglutamate residues of osteocalcin in patients on hemodialysis","volume":"58","author":"Saupe","year":"1993","journal-title":"Am J Clin Nutr"},{"key":"10.1054\/mehy.2001.1307_RF10","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1359\/jbmr.1999.14.7.1175","article-title":"Apolipoprotein E polymorphism: a new genetic marker of hip fracture risk \u2013 the study of osteoporotic fractures","volume":"14","author":"Cauley","year":"1999","journal-title":"J Bone Miner Res"},{"key":"10.1054\/mehy.2001.1307_RF11","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1111\/j.1532-5415.1999.tb07436.x","article-title":"APOE 4 and hip fracture risk in a community-based study of older adults","volume":"47","author":"Johnston","year":"1999","journal-title":"J Am Geriatr Soc"},{"key":"10.1054\/mehy.2001.1307_RF12","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1079\/BJN19940043","article-title":"Vitamin K distribution in rat tissues: dietary phylloquinone is a source of tissue menaquinone-4","volume":"72","author":"Thijssen","year":"1994","journal-title":"Br J Nutr"},{"key":"10.1054\/mehy.2001.1307_RF13","first-page":"2746","article-title":"Vitamin K status influences brain sulfatide metabolism in young mice and rats","volume":"126","author":"Sundaram","year":"1996","journal-title":"J Nutr"},{"key":"10.1054\/mehy.2001.1307_RF14","first-page":"229","article-title":"Intrauterine effects of coumarin derivatives","volume":"6","author":"Pauli","year":"1993","journal-title":"Dev Brain Dysfunct"},{"key":"10.1054\/mehy.2001.1307_RF15","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0022-2275(20)39399-8","article-title":"Effect of vitamin K depletion and restoration on sphingolipid metabolism in Bacteroides melaninogenicus","volume":"13","author":"Lev","year":"1972","journal-title":"J Lipid Res"},{"key":"10.1054\/mehy.2001.1307_RF16","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1016\/S0022-2275(20)38426-1","article-title":"Warfarin administration reduces synthesis of sulfatides and other sphingolipids in brain","volume":"29","author":"Sundaram","year":"1988","journal-title":"J Lipid Res"},{"key":"10.1054\/mehy.2001.1307_RF17","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0003-9861(90)90557-F","article-title":"Regulation of sulfotransferase activity by vitamin K in mouse brain","volume":"277","author":"Sundaram","year":"1990","journal-title":"Arch Biochem Biophys"},{"key":"10.1054\/mehy.2001.1307_RF18","doi-asserted-by":"crossref","first-page":"16991","DOI":"10.1074\/jbc.271.29.16991","article-title":"Selective loss of cerebral keratan sulfate in Alzheimer\u2019s disease","volume":"271","author":"Lindahl","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1054\/mehy.2001.1307_RF19","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/BF01923587","article-title":"Nervous tissue proteoglycans","volume":"49","author":"Margolis","year":"1993","journal-title":"Experientia"},{"key":"10.1054\/mehy.2001.1307_RF20","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1471-4159.1993.tb03535.x","article-title":"The SV-2 protein of synaptic vesicles is a keratan sulfate proteoglycan","volume":"61","author":"Scranton","year":"1993","journal-title":"J Neurochem"},{"key":"10.1054\/mehy.2001.1307_RF21","doi-asserted-by":"crossref","first-page":"5778","DOI":"10.1021\/bi00140a013","article-title":"Linkage of the acetylcholine transporter-vesamicol receptor to proteoglycan in synaptic vesicles","volume":"31","author":"Bahr","year":"1992","journal-title":"Biochemistry"},{"key":"10.1054\/mehy.2001.1307_RF22","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1006\/exnr.1996.0069","article-title":"Identification and immunolocalization of a new class of proteoglycan (keratan sulfate) to the neuritic plaques of Alzheimer\u2019s disease","volume":"138","author":"Snow","year":"1996","journal-title":"Exp Neurol"},{"key":"10.1054\/mehy.2001.1307_RF23","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/S0006-8993(98)01159-7","article-title":"Gas 6, a ligand for the receptor tyrosine kinase tyro 3, is widely expressed in the central nervous system","volume":"816","author":"Prieto","year":"1999","journal-title":"Brain Res"},{"key":"10.1054\/mehy.2001.1307_RF24","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1042\/bj3230387","article-title":"Requirement of \u03b3-carboxyglutamic acid residues for the biological activity of Gas 6: contribution of endogenous Gas 6 to the proliferation of vascular smooth muscle cells","volume":"323","author":"Nakano","year":"1977","journal-title":"Biochem J"},{"key":"10.1054\/mehy.2001.1307_RF25","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1523\/JNEUROSCI.16-06-02012.1996","article-title":"Identification of Gas 6 as a growth factor for human Schwann cells","volume":"16","author":"Li.","year":"1996","journal-title":"J Neurosci"},{"key":"10.1054\/mehy.2001.1307_RF26","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1210\/mend.13.2.0230","article-title":"Growth arrest-specific gene 6 (gas 6)\/adhesion related kinase (Ark) signaling promotes gonadotropin-releasing hormone neuronal survival via extracellular signal related kinase (ERK) and Akt","volume":"13","author":"Allen","year":"1999","journal-title":"Mol Endocrinol"},{"key":"10.1054\/mehy.2001.1307_RF27","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1172\/JCI119202","article-title":"A novel role for vitamin K1in a tyrosine phosphorylation cascade during chick embryogenesis","volume":"99","author":"Saxena","year":"1977","journal-title":"J Clin Invest"},{"key":"10.1054\/mehy.2001.1307_RF28","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1753-4887.1999.tb06950.x","article-title":"Vitamin K-dependent proteins in the developing and aging nervous system","volume":"57","author":"Tsaioun","year":"1999","journal-title":"Nutr Revs"},{"key":"10.1054\/mehy.2001.1307_RF29","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1161\/01.STR.30.8.1548","article-title":"Impact of apolipoprotein E4 and vascular disease on brain morphology in men from the NHLBI twin study","volume":"30","author":"De Carli","year":"1999","journal-title":"Stroke"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987701913076?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987701913076?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,5,16]],"date-time":"2021-05-16T06:41:09Z","timestamp":1621147269000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987701913076"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,8]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2001,8]]}},"alternative-id":["S0306987701913076"],"URL":"https:\/\/doi.org\/10.1054\/mehy.2001.1307","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2001,8]]}}}